Researchers tested a new formulation of undecylenic acid (a fatty acid already used as an antifungal) combined with L-Arginine and found it killed cancer cells in lab tests by triggering a specific cell death pathway. The compound worked in a dose-dependent way, meaning higher concentrations were more effective, and it bypassed the cell's usual protective mechanisms against fatty acids.

Scientists created a new way to dissolve undecylenic acid using amino acids, then tested this formulation on tumor cells in a lab setting to understand how it worked at the cellular level.

Funding not disclosed in abstract